Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange Detected- Add: government funding notice, new topic on diffuse large B-cell lymphoma, and version bump to v3.2.0; - Remove: old version tag v3.1.0.SummaryDifference2%

- Check36 days agoChange DetectedUpgraded to v3.1.0 by removing the topic 'Diffuse large B-cell lymphoma' from resources and keeping the version label as the primary change.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision updated to v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated to include new drug information and a revised facility name and location, while removing previous details about certain drugs and related topics. Notably, the addition of specific drugs like cyclophosphamide and fludarabine enhances the core content related to treatment options for diffuse large B-cell lymphoma.SummaryDifference4%

- Check79 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.